Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
TECHNETIUM GENERATOR
TECHNETIUM GENERATORIt is indicated for obtaining a solution of Sodium Pertechnetate (Tc99m) ... -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...

